<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_SDU-Denmark_Tour54 skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:SDU-Denmark/Tour54</SPAN></H1><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="BackgroundLayout"><DIV class="top bannerShadow"><DIV class="NavbarContainer"><DIV class="NavbarContainerInner"><DIV class="MenuButton" id="btnWelcome"><A class="MenuButtonLink" href="https://2015.igem.org/Team:SDU-Denmark">Welcome</A></DIV><DIV class="MenuButton" id="btnTour"><A class="MenuButtonLink" href="https://2015.igem.org/Team:SDU-Denmark/Tour10">Interactive wiki-tour</A></DIV><DIV class="MenuButton" id="btnMenu"><A class="MenuButtonLink" href="#" id="btnMenu2">Menu</A><DIV class="menuPopup"><DIV class="menuPopupContent"><DIV class="menuPopupContentInner bannerShadow"><DIV class="menuIntro"><DIV class="warningBox"><P class="menuIntro">
You really should try our <A href="https://2015.igem.org/Team:SDU-Denmark/Tour10">interactive wiki tour</A> instead! 

</P></DIV><P class="menuIntro">
But if you are looking for a specific page - you are in the right place. 
</P><DIV class="menuItems"><UL><LI class="header"><A href="https://2015.igem.org/Team:SDU-Denmark/Tour10">Introduction</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour11">The Team</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour12">Attributions</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour13">Gallery</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour14">Medal Requirements</A></LI></UL><UL><LI class="header"><A href="https://2015.igem.org/Team:SDU-Denmark/Tour20"> Antibody Issue</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour21">Antibody Production</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour22">Animal Ethics</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour23">The Alternative</A></LI></UL><UL><LI class="header"><A href="https://2015.igem.org/Team:SDU-Denmark/Tour30">PAST</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour31">Two-Hybrid Screening</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour32">System Design</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour33">Business</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour34">Entrepreneurship</A></LI></UL><UL><LI class="header"><A href="https://2015.igem.org/Team:SDU-Denmark/Tour40">Process</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour41">Complete Journal</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour42">Collaborations</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour43">SOPs</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour44">Safety</A></LI></UL><UL><LI class="header"><A href="https://2015.igem.org/Team:SDU-Denmark/Tour50">Results</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour51">Characterization</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour52">Two-Hybrid System</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour53">Submitted Parts</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour54">Interlab Study</A></LI></UL><UL><LI class="header"><A href="https://2015.igem.org/Team:SDU-Denmark/Tour60">Practices</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour61">Survey</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour62">Education</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour63">Ethics</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour64">A Children's Book</A></LI></UL><UL><LI class="header"><A href="https://2015.igem.org/Team:SDU-Denmark/Tour70">
What is Next?</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour71">Challenges and Limitations</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour72">Medical Aspects</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour72">Lab Work</A></LI><LI><A href="https://2015.igem.org/Team:SDU-Denmark/Tour73">The End</A></LI></UL></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV><DIV class="tourBoundingBox"><DIV class="tourBoundingBoxInner bannerShadow"><DIV class="parentTourItem "><A class="tourItemLabel" title="Get a brief overview of the project.">
                Introduction
            </A></DIV><DIV class="expandedTour" style="display:none"><DIV class="expandedTourInner"><DIV class="parentTourItem"><A class="tourItemLabel" title="Would you like to meet our team?">
                       The Team
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="To express our thankfulness.">
                        Attributions
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        Gallery
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        Medal Requirements
                    </A></DIV></DIV></DIV><DIV class="parentTourItem "><A class="tourItemLabel" title="">
               Antibody issue
            </A></DIV><DIV class="expandedTour" style="display:none"><DIV class="expandedTourInner"><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                       Antibody production
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        Animal Ethics
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        The Alternative
                    </A></DIV></DIV></DIV><DIV class="parentTourItem "><A class="tourItemLabel" title="">
                PAST            </A></DIV><DIV class="expandedTour" style="display:none"><DIV class="expandedTourInner"><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        Two-Hybrid Screening
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        System Design
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        Business
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                       Entrepreneurship
                    </A></DIV></DIV></DIV><DIV class="parentTourItem "><A class="tourItemLabel" title="">
                Process
            </A></DIV><DIV class="expandedTour" style="display:none"><DIV class="expandedTourInner"><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        Complete Journal
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        Collaborations
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                       SOPs
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        Safety
                    </A></DIV></DIV></DIV><DIV class="parentTourItem "><A class="tourItemLabel" title="">       Results
            </A></DIV><DIV class="expandedTour" style="display:none"><DIV class="expandedTourInner"><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        Characterization
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                      Two-Hybrid System
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                       Submitted Parts
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        Interlab Study
                    </A></DIV></DIV></DIV><DIV class="parentTourItem "><A class="tourItemLabel" title="">
Practices
            </A></DIV><DIV class="expandedTour" style="display:none"><DIV class="expandedTourInner"><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        Survey
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        Education
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        Ethics
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title=""> A Childrenâ€™s Book
                    </A></DIV></DIV></DIV><DIV class="parentTourItem "><A class="tourItemLabel" title="">
               What is Next
            </A></DIV><DIV class="expandedTour" style="display:none"><DIV class="expandedTourInner"><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        Challenges and Limitations
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        Medical Aspects
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                        Lab Work
                    </A></DIV><DIV class="parentTourItem"><A class="tourItemLabel" title="">
                      The End
                    </A></DIV></DIV></DIV></DIV></DIV><DIV class="MainLayout"><DIV class="content"><P><I> &quot;In a dark place we find ourselves, and a little more knowledge lights our way.&quot; - <B>George Lucas</B></I></P><H1 align="center"> Interlab study </H1><P><SPAN class="intro">Our team has been participating</SPAN> in the iGEM <A href="https://2015.igem.org/Tracks/Measurement/Interlab_study" target="_blank">Interlab Study</A>, to help further characterize three different promoters. This was done by using GFP-fluorescence as a way of measuring how strong each of the promoters are compared to each other.
</P><DIV class="thumb tright"><DIV class="thumbinner" style="width:255px;height:335px;"><DIV class="thumbcaption">Figure 1:The three constructs made for this experiment.
</DIV></DIV></DIV><P><SPAN class="intro">The three constructs were made</SPAN> through iGEM standard biobrick assembly, inserting <I>gfp</I> into pSB1C3 plasmids containing the different promoters. The <I>gfp</I>-gene were originally cut out of pSB1A2, before ligation with each of the three promotes. Transformation of the constructs was done into <I>E. coli</I> K12 Top10, because it has been optimized for transformation and high levels of plasmid synthetisati<SPAN class="sourceReference">on</SPAN>.
<SPAN class="tooltip"><SPAN class="tooltipHeader">Reference:</SPAN>One ShotÂ® Top10 Chemically Competent <I>E. coli</I>. Catalog number: C4040-10. Visited: 17.09.15.<A target="_blank" href="https://www.thermofisher.com/order/catalog/product/C404010 "> [ThermoFisher] </A></SPAN>


According to iGEM headquarter protocol, biological triplets and technical triplicates was made for each promoter. Each construct has been sequenced and verified with colony PCR. For the complete protocol click <A href="https://static.igem.org/mediawiki/2015/5/5a/SDU_2015_Protocol_003_-_Interlab_Study.pdf" target="_blank">here</A>. 
Each construct were sequenced; two of the constructs were correctly assembled, the third had the correct promoter, but the remaining did not match <I>gfp</I>.
</P><P><SPAN class="intro">For the measurements conducted in this project</SPAN> we used a FACSAriaII. The used method of the FACS were flow cytometry which functions through singling out droplets containing one cell each.
By exciting the proteins with light on the absorption frequency of the protein the cells will be fluorescent and emission intensity can be measured.
We used <I>E. coli</I> Top10 without inserted plasmids as our negative control and one of our own biobricks; pSB1C3-T18-LinkerGFP for the positive control. Top10 was used to calibrate the FACS and the arbitrary units (a.u.) was measured by gating.
Arbitrary units are relative to the measurements, it describes how strong one reading is compared to a defined referen<SPAN class="sourceReference">ce</SPAN>.
<SPAN class="tooltip"><SPAN class="tooltipHeader">Reference:</SPAN>Kate B. Bechtol, David K. Hanzel, and Bee
Choo Liang, Amersham Biosciences, Inc. - Understanding Fluorescence.<A target="_blank" href="https://www.gelifesciences.com/gehcls_images/GELS/Related%20Content/Files/1314729545976/litdoc63002879_20110830221802.pdf "> [GelifeSciences] </A></SPAN></P><P><SPAN class="intro">The three promoters are part</SPAN> of a promoter family originally from a combinatorial library made by John Anderson in 2006. WT J23119 was made from synthetic oligonucleotides using overlap extension, and is the strongest of all the promoters in the family<SPAN class="sourceReference">REFERENCE WORD</SPAN>.
<SPAN class="tooltip"><SPAN class="tooltipHeader">Reference:</SPAN>iGEM Parts Registry - BBa_J23119:Design. Visited: 17.09.15.<A target="_blank" href="http://parts.igem.org/Part:BBa_J23119:Design "> [Parts] </A></SPAN>

J23101 is a constitutive promoter mutated form the WT J23119, and contains one point mutation in position -33, subsstituting G with T. J23106 and J23117, like J23101, are derivatives of J23119, and are also constitutive promoters and modified in the same manner. J23106 have three mutations one in the -10 region and two in the -35 region, 8- and -9 plus -33 and -32, respectively. J23117 have two mutations in its -10 region, at position -8 and -12. All three promoters are 35 bp lo<SPAN class="sourceReference">ng</SPAN>.
<SPAN class="tooltip"><SPAN class="tooltipHeader">Reference:</SPAN>JCAnderson. iGEM Parts Registry - Visited: 17.09.15.<A target="_blank" href="http://parts.igem.org/File:PBca1020-r0040.jpg "> [Parts] </A></SPAN></P><DIV class="thumb tright"><DIV class="thumbinner" style="width:255px;height:395px;"><DIV class="thumbcaption">Figure 2: The diagram shows the flourescence measured in a.u. by FACS for the 5 constructs. The P-value derived from the data is P&lt;0.0001, marked by ****. J23106+I13504 has the highest flourescence measured, while Top10 has the lowest. 
</DIV></DIV></DIV><A href="http://parts.igem.org/Part:BBa_I13504" target="_blank">BBa_I13504</A> is a composite part composed of and RBS-site, a FACS optimized GFPmut3b and two standard biobrick terminators. The GFPmut3b has amino acid substitutions in position 65 and 72, a Glycine and Alanine respective<SPAN class="sourceReference">ly</SPAN>.
<SPAN class="tooltip"><SPAN class="tooltipHeader">Reference:</SPAN>Brendan P. Cormack, Raphael H. Valdiviaa, Stanley Falkow - FACS-optimized mutants of the green fluorescent protein (GFP). DOI:10.1016/0378-1119(95)00685-0.<A target="_blank" href="http://www.sciencedirect.com/science/article/pii/0378111995006850 "> [ScienceDirect] </A></SPAN><P><SPAN class="intro">Top10 is the reference for the a.u. measurements</SPAN> compared to each of the other samples.
Our expectations of the promoters are listed from weakest to strongest in relative expression: J23117 &lt; J23106 &lt; J23101, based on the original measurements done in 2006. 
In figure 2 a graph comparing each constructâ€™s a.u. to the positive control, T18-Linker-GFP is depicted. The scale is logarithmic due to the relatively large difference in the measured expression levels of the promoters. 
</P><P><SPAN class="intro">Sequence data for the three constructs</SPAN> was compared to the sequence retrieved from parts registry. It was correct for <A href="https://static.igem.org/mediawiki/2015/a/a5/Sdu_2015_J23106%2BI13504.txt" target="_blank">J23106-I13504</A> and <A href="https://static.igem.org/mediawiki/2015/3/33/Sdu_2015_J23117%2BI13504.txt" target="_blank">J23117-I13504</A>, but the data for <A href="https://static.igem.org/mediawiki/2015/1/15/Sdu_2015_J23101%2BI13504.txt" target="_blank">J23101-I13504</A> did not show the gene encoding GFP, a BLAST search showed some alignment in the beginning of the sequence, to pFM46. Promoter J23106 showed the highest fluorescence of the constructs, with J23117 having a significantly (p &lt; 0.0001) reduced fluorescence, at 40 times lower.
</P><P><SPAN class="intro">The J23106 construct showed a much higher</SPAN> fluorescence than the J23117 construct, with a mean value of 85932 a.u. compared to 814 a.u. see figure 2 for graph.
The measurement on J23101 is inconclusive in this study, due to the wrongful sequence, possibly caused by contamination.
</P></DIV><DIV class="footer "><DIV class="footerContainer"><A class="footerBtn footerShadow" id="btnFastForward"><P class="footerBtnPre">Next chapter
</P></A><A class="footerBtn footerShadow" id="btnNextChapter"><P class="footerBtnPre">Next chapter
</P></A><A class="footerBtn footerShadow" id="btnDigDeeper"><P class="footerBtnPre">Dig deeper
</P></A><A class="footerBtn footerShadow" id="btnTheEnd" href="http://www.igem.org" target="_blank"><P class="footerBtnPre">End of tour
</P><P class="footerBtnHeader" style="text-transform: none !important;">Want more? Go to iGEM.org!</P><P class="footerBtnText">
If you want to learn more about Synthetic Biology you should visit iGEM's homepage, which contains loads on the subject. You can even visit other teams' wikis and take a look at what they accomplished. Or maybe join a team yourself?</P></A></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>